The Federal Trade Commission has released its 2013 Annual Highlights, commending some of the high points in the agency’s year.
According to reports, FTC chairwoman Edith Ramirez made a point to emphasize the regulator’s work in pharmaceutical mergers as officials look for ways to crack down on anticompetitive behavior resulting from pay-for-delay schemes, in which brand name companies pay generic companies to delay the release of their cheaper product.
Included in the highlights was the FTC’s challenge of generic drug maker Mylan’s plans to acquire Aguila Specialties in a $1.85 billion deal.
Not surprisingly, the FTC also highlighted its decision to require generic drug maker Actavis to divest rights and assets to four drugs following its acquisition of Warner Chilcott, made for $8.5 billion. That deal was cleared by the regulator late last year.
Perhaps the most significant highlight for the watchdog was the Supreme Court’s ruling last year that allowed pay-for-delay deals to be scrutinized by antitrust regulators in a reversal of an earlier ruling in FTC v. Actavis.
Full Content: The Pharma Letter
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI